Forxiga 10 mg film-coated tablets

Forxiga is a prescription medication containing the active ingredient dapagliflozin, formulated as 10 mg film-coated tablets. The product identified by PZN (Pharmazentralnummer) 10330193 is a standard pack of 28 tablets sold in the German market. It is primarily used to treat type 2 diabetes mellitus, symptomatic chronic heart failure, and chronic kidney disease by helping the kidneys remove glucose from the blood through urine.

The brand Forxiga was developed by AstraZeneca in collaboration with Bristol-Myers Squibb, though AstraZeneca later acquired provide full rights to the diabetes franchise. AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company. Manufacturing of such a global product typically occurs across several high-tech facilities worldwide, including major sites in the United Kingdom, Sweden, and Germany, ensuring a stable supply for the European market through its local subsidiary, AstraZeneca GmbH.